{"id":353735,"date":"2025-08-28T09:46:51","date_gmt":"2025-08-28T09:46:51","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-incyte-corporation\/"},"modified":"2025-08-28T09:46:51","modified_gmt":"2025-08-28T09:46:51","slug":"how-to-buy-incyte-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/","title":{"rendered":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353735","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Incyte Corporation (INCY) hisseleri nas\u0131l al\u0131n\u0131r ve INCY hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. Bu biyofarmas\u00f6tik liderin g\u00fcncel fiyat\u0131n\u0131, trendlerini, risklerini ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Incyte Corporation (INCY) hisseleri nas\u0131l al\u0131n\u0131r ve INCY hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. Bu biyofarmas\u00f6tik liderin g\u00fcncel fiyat\u0131n\u0131, trendlerini, risklerini ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Kanser tedavisinde devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Incyte Corporation, d\u00fcnya \u00e7ap\u0131nda hastalar i\u00e7in hayat de\u011fi\u015ftiren tedaviler geli\u015ftiren hassas t\u0131bb\u0131n \u00f6nc\u00fcs\u00fcd\u00fcr. G\u00fc\u00e7l\u00fc son kazan\u00e7lar\u0131 ve yenilik\u00e7i ila\u00e7 hatt\u0131 ile bu biyoteknoloji lideri, b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcyle ilgilenen ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz f\u0131rsatlar sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kanser tedavisinde devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Incyte Corporation, d\u00fcnya \u00e7ap\u0131nda hastalar i\u00e7in hayat de\u011fi\u015ftiren tedaviler geli\u015ftiren hassas t\u0131bb\u0131n \u00f6nc\u00fcs\u00fcd\u00fcr. G\u00fc\u00e7l\u00fc son kazan\u00e7lar\u0131 ve yenilik\u00e7i ila\u00e7 hatt\u0131 ile bu biyoteknoloji lideri, b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcyle ilgilenen ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz f\u0131rsatlar sunuyor."},"body_html":"<h2>\ud83d\udcc8 Incyte Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, Incyte Corporation (INCY) NASDAQ borsas\u0131nda <strong>84,84 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. \u015eirket, biyoteknoloji sekt\u00f6r\u00fcnde ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi ve \u015fu anda 52 haftal\u0131k en y\u00fcksek seviyesi olan 87,24 $'\u0131n sadece %2,1 alt\u0131nda bulunuyor.<\/p> <p><strong>Takviminize not edin: Ekim 2025 kritik<\/strong> - Incyte'in bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klamas\u0131 bekleniyor. Tarihsel olarak, bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirdi\u011finden, hem mevcut hissedarlar hem de potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir tarih.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 INCY Hissesini Nas\u0131l Etkiler?<\/h3> <p>Son performans desenlerine bakmak, yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sunar:<\/p> <ul> <li><strong>29 Nisan 2025<\/strong>: Tahminleri 0,15 $ a\u015fan 1,16 $ EPS ile 1. \u00e7eyrek kazan\u00e7 a\u00e7\u0131klamas\u0131 - hisse ivme kazand\u0131<\/li> <li><strong>29 Temmuz 2025<\/strong>: 1,39 $ beklentisine kar\u015f\u0131 1,57 $ d\u00fczeltilmi\u015f EPS ile 2. \u00e7eyrek kazan\u00e7lar\u0131 - g\u00fc\u00e7l\u00fc olumlu tepki<\/li> <li>Y\u0131ll\u0131k %16 gelir art\u0131\u015f\u0131 ile 1,22 milyar $ operasyonel g\u00fc\u00e7 g\u00f6sterdi<\/li> <\/ul> <p>Desen, tutarl\u0131 kazan\u00e7 a\u015fmalar\u0131n\u0131 g\u00f6steriyor; bu da y\u00f6netimin rehberli\u011finin muhafazakar oldu\u011funu ve ger\u00e7ek performans\u0131n genellikle beklentileri a\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2> <p>Incyte hisseleri, piyasa dalgalanmas\u0131 aras\u0131nda etkileyici bir istikrar g\u00f6sterdi; <strong>ge\u00e7en y\u0131l %3,03 getiri sa\u011flarken<\/strong> genel sa\u011fl\u0131k sekt\u00f6r\u00fc %10,83 d\u00fc\u015ft\u00fc. \u0130\u015fte detaylar:<\/p> <p><strong>Ocak-Mart 2025<\/strong>: 68-72 $ aral\u0131\u011f\u0131nda konsolidasyon d\u00f6nemi<br\/> <strong>Nisan 2025<\/strong>: G\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n ard\u0131ndan k\u0131r\u0131lma, 78 $ seviyesine ula\u015ft\u0131<br\/> <strong>May\u0131s-Temmuz 2025<\/strong>: S\u00fcrekli iyimserlikle 82-85 $ aral\u0131\u011f\u0131na istikrarl\u0131 t\u0131rman\u0131\u015f<br\/> <strong>A\u011fustos 2025<\/strong>: 52 haftal\u0131k zirvelerde 84,84 $ civar\u0131nda diren\u00e7 testi<\/p> <p>Hissenin son 52 haftadaki ortalama fiyat\u0131 68,60 $ olup, mevcut fiyat\u0131n \u00f6nemli bir prim temsil etti\u011fi - g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f sinyali.<\/p> <h3>Yukar\u0131 y\u00f6nl\u00fc ivmenin nedeni nedir?<\/h3> <ul> <li><strong>Jakafi sat\u0131\u015f b\u00fcy\u00fcmesi<\/strong>: 2. \u00e7eyrekte y\u0131ll\u0131k %8 art\u0131\u015fla 763,8 milyon $<\/li> <li><strong>Opzelura patlamas\u0131<\/strong>: %35 sat\u0131\u015f art\u0131\u015f\u0131 ile 164,5 milyon $<\/li> <li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 2,4 milyar $ finansal esneklik sa\u011fl\u0131yor<\/li> <li><strong>Analist y\u00fckseltmeleri<\/strong>: 2025 mali y\u0131l\u0131 i\u00e7in EPS tahminleri 4,75 $'dan 5,06 $'ya y\u00fckseldi<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 81-85 $ aral\u0131\u011f\u0131 (mevcut seviyeleri koruyarak hafif yukar\u0131 potansiyel)<br\/> <strong>2026<\/strong>: 78-83 $ (piyasan\u0131n b\u00fcy\u00fcmeyi sindirmesiyle konsolidasyon d\u00f6nemi)<br\/> <strong>2028<\/strong>: 70-75 $ (patent endi\u015feleriyle \u0131l\u0131ml\u0131 d\u00fc\u015f\u00fc\u015f)<br\/> <strong>2030<\/strong>: 60-65 $ (rekabetten kaynaklanan uzun vadeli bask\u0131)<\/p> <p><strong>Karar<\/strong>: Mevcut yat\u0131r\u0131mc\u0131lar i\u00e7in TUT, yeni al\u0131c\u0131lar i\u00e7in daha iyi giri\u015f noktalar\u0131 bekleyin<\/p> <p>Geni\u015f analist hedef aral\u0131\u011f\u0131 (60-107 $) ila\u00e7 hatt\u0131 ba\u015far\u0131s\u0131 ve rekabet bask\u0131lar\u0131 hakk\u0131nda \u00f6nemli belirsizli\u011fi yans\u0131t\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Patent s\u00fcresi dolmas\u0131<\/strong>: Jakafi'nin nihai patent u\u00e7urumu riski<\/li> <li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir<\/li> <li><strong>Rekabet<\/strong>: Miyelofibroz tedavi alan\u0131nda yeni oyuncular<\/li> <li><strong>Ar-Ge ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u0130la\u00e7 hatt\u0131 ba\u015far\u0131s\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 ivmesi<\/strong>: Son \u00e7eyreklerde tutarl\u0131 a\u015fmalar<\/li> <li><strong>\u00dcr\u00fcn \u00e7e\u015fitlendirmesi<\/strong>: Opzelura'n\u0131n ba\u015far\u0131l\u0131 lansman\u0131 Jakafi ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azalt\u0131yor<\/li> <li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: Stratejik sat\u0131n almalar i\u00e7in 2,4 milyar $<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: B\u00fcy\u00fcyen hassas t\u0131p pazar\u0131<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Geri \u00e7ekilmeyi bekleyin<\/strong>: Mevcut fiyatlar 52 haftal\u0131k zirvelere yak\u0131n, sab\u0131rl\u0131 olun<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Toplu yerine k\u00fc\u00e7\u00fck, d\u00fczenli yat\u0131r\u0131mlar\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Hisse 75-78 $ destek b\u00f6lgesine d\u00fc\u015ferse sat\u0131n al\u0131n<\/li> <li><strong>Portf\u00f6y\u00fc \u00e7e\u015fitlendirin<\/strong>: Biyoteknoloji tahsisini %5-10 ile s\u0131n\u0131rlay\u0131n<\/li> <\/ol> <p>Espiri: \"INCY ticareti yapmak, klinik deneme sonu\u00e7lar\u0131n\u0131 beklemek gibidir - bazen o at\u0131l\u0131m an\u0131 i\u00e7in sab\u0131rl\u0131 olman\u0131z gerekir!\"<\/p> <h2>\u2705 Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>INCY hakk\u0131nda kapsaml\u0131 ara\u015ft\u0131rma yap\u0131n<\/td><td>\u015eirketin \u00fcr\u00fcnlerini ve risklerini anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Giri\u015f stratejinizi belirleyin<\/td><td>Al\u0131m fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Pozisyonunuzu izleyin ve y\u00f6netin<\/td><td>Stop-loss ve kar hedefleri belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, INCY gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong> tek belgeli KYC ile h\u0131zl\u0131ca i\u015flem yapman\u0131z\u0131 sa\u011flar<\/li> <li><strong>Kripto paralar ve e-c\u00fczdanlar dahil<\/strong> \u00e7oklu para \u00e7ekme se\u00e7enekleri<\/li> <li><strong>Karma\u015f\u0131kl\u0131ktan uzak, kullan\u0131c\u0131 dostu platform<\/strong> yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015ft\u0131r<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, piyasalar\u0131 \u00f6\u011frenirken k\u00fc\u00e7\u00fck ba\u015flamay\u0131 isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Incyte: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Incyte Corporation, kanser tedavisinde yenilik\u00e7i yakla\u015f\u0131m\u0131yla hassas t\u0131p alan\u0131nda liderdir. \u015eirketin i\u015f modeli, <a href=\"https:\/\/dcfmodeling.com\/products\/incy-business-model-canvas\">onkoloji ve nadir hastal\u0131klar i\u00e7in hedefe y\u00f6nelik tedavilere<\/a> odaklanmakta olup, genomik test kapsam\u0131 ileri evre kanser hastalar\u0131n\u0131n %89'una ula\u015fmaktad\u0131r.<\/p> <p>\u015eirketin amiral gemisi ila\u00e7 <strong>Jakafi<\/strong> y\u0131lda yakla\u015f\u0131k 1,74 milyar $ gelir sa\u011flarken, <strong>Opzelura<\/strong> gibi yeni \u00fcr\u00fcnler y\u0131ll\u0131k %35 patlay\u0131c\u0131 b\u00fcy\u00fcme g\u00f6stermektedir. <a href=\"https:\/\/www.fiercepharma.com\/pharma\/incyte-ceo-turn-lot-cards-2025-eyes-2-types-deals\">2025 i\u00e7in planlanan d\u00f6rt \u00fcr\u00fcn lansman\u0131 ve d\u00f6rt kritik sonu\u00e7<\/a> ile \u015firket, kanser ve imm\u00fcnoloji alanlar\u0131nda yenilik yapmaya devam ediyor.<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Incyte'in ara\u015ft\u0131rmalar\u0131, molek\u00fcler profilleme yoluyla %93,7 hedefe y\u00f6nelik tedavi e\u015fle\u015fme oran\u0131 elde etti\u011fini g\u00f6steriyor; yani genomik test yapt\u0131ran neredeyse t\u00fcm hastalar uygun hedefe y\u00f6nelik tedavi ile e\u015fle\u015fiyor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Incyte Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, Incyte Corporation (INCY) NASDAQ borsas\u0131nda <strong>84,84 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. \u015eirket, biyoteknoloji sekt\u00f6r\u00fcnde ola\u011fan\u00fcst\u00fc bir dayan\u0131kl\u0131l\u0131k g\u00f6sterdi ve \u015fu anda 52 haftal\u0131k en y\u00fcksek seviyesi olan 87,24 $&#8217;\u0131n sadece %2,1 alt\u0131nda bulunuyor.<\/p>\n<p><strong>Takviminize not edin: Ekim 2025 kritik<\/strong> &#8211; Incyte&#8217;in bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klamas\u0131 bekleniyor. Tarihsel olarak, bu raporlar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirdi\u011finden, hem mevcut hissedarlar hem de potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6nemli bir tarih.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 INCY Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>Son performans desenlerine bakmak, yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sunar:<\/p>\n<ul>\n<li><strong>29 Nisan 2025<\/strong>: Tahminleri 0,15 $ a\u015fan 1,16 $ EPS ile 1. \u00e7eyrek kazan\u00e7 a\u00e7\u0131klamas\u0131 &#8211; hisse ivme kazand\u0131<\/li>\n<li><strong>29 Temmuz 2025<\/strong>: 1,39 $ beklentisine kar\u015f\u0131 1,57 $ d\u00fczeltilmi\u015f EPS ile 2. \u00e7eyrek kazan\u00e7lar\u0131 &#8211; g\u00fc\u00e7l\u00fc olumlu tepki<\/li>\n<li>Y\u0131ll\u0131k %16 gelir art\u0131\u015f\u0131 ile 1,22 milyar $ operasyonel g\u00fc\u00e7 g\u00f6sterdi<\/li>\n<\/ul>\n<p>Desen, tutarl\u0131 kazan\u00e7 a\u015fmalar\u0131n\u0131 g\u00f6steriyor; bu da y\u00f6netimin rehberli\u011finin muhafazakar oldu\u011funu ve ger\u00e7ek performans\u0131n genellikle beklentileri a\u015ft\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu ve Trend Analizi<\/h2>\n<p>Incyte hisseleri, piyasa dalgalanmas\u0131 aras\u0131nda etkileyici bir istikrar g\u00f6sterdi; <strong>ge\u00e7en y\u0131l %3,03 getiri sa\u011flarken<\/strong> genel sa\u011fl\u0131k sekt\u00f6r\u00fc %10,83 d\u00fc\u015ft\u00fc. \u0130\u015fte detaylar:<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: 68-72 $ aral\u0131\u011f\u0131nda konsolidasyon d\u00f6nemi<br \/> <strong>Nisan 2025<\/strong>: G\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n ard\u0131ndan k\u0131r\u0131lma, 78 $ seviyesine ula\u015ft\u0131<br \/> <strong>May\u0131s-Temmuz 2025<\/strong>: S\u00fcrekli iyimserlikle 82-85 $ aral\u0131\u011f\u0131na istikrarl\u0131 t\u0131rman\u0131\u015f<br \/> <strong>A\u011fustos 2025<\/strong>: 52 haftal\u0131k zirvelerde 84,84 $ civar\u0131nda diren\u00e7 testi<\/p>\n<p>Hissenin son 52 haftadaki ortalama fiyat\u0131 68,60 $ olup, mevcut fiyat\u0131n \u00f6nemli bir prim temsil etti\u011fi &#8211; g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f sinyali.<\/p>\n<h3>Yukar\u0131 y\u00f6nl\u00fc ivmenin nedeni nedir?<\/h3>\n<ul>\n<li><strong>Jakafi sat\u0131\u015f b\u00fcy\u00fcmesi<\/strong>: 2. \u00e7eyrekte y\u0131ll\u0131k %8 art\u0131\u015fla 763,8 milyon $<\/li>\n<li><strong>Opzelura patlamas\u0131<\/strong>: %35 sat\u0131\u015f art\u0131\u015f\u0131 ile 164,5 milyon $<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 2,4 milyar $ finansal esneklik sa\u011fl\u0131yor<\/li>\n<li><strong>Analist y\u00fckseltmeleri<\/strong>: 2025 mali y\u0131l\u0131 i\u00e7in EPS tahminleri 4,75 $&#8217;dan 5,06 $&#8217;ya y\u00fckseldi<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 81-85 $ aral\u0131\u011f\u0131 (mevcut seviyeleri koruyarak hafif yukar\u0131 potansiyel)<br \/> <strong>2026<\/strong>: 78-83 $ (piyasan\u0131n b\u00fcy\u00fcmeyi sindirmesiyle konsolidasyon d\u00f6nemi)<br \/> <strong>2028<\/strong>: 70-75 $ (patent endi\u015feleriyle \u0131l\u0131ml\u0131 d\u00fc\u015f\u00fc\u015f)<br \/> <strong>2030<\/strong>: 60-65 $ (rekabetten kaynaklanan uzun vadeli bask\u0131)<\/p>\n<p><strong>Karar<\/strong>: Mevcut yat\u0131r\u0131mc\u0131lar i\u00e7in TUT, yeni al\u0131c\u0131lar i\u00e7in daha iyi giri\u015f noktalar\u0131 bekleyin<\/p>\n<p>Geni\u015f analist hedef aral\u0131\u011f\u0131 (60-107 $) ila\u00e7 hatt\u0131 ba\u015far\u0131s\u0131 ve rekabet bask\u0131lar\u0131 hakk\u0131nda \u00f6nemli belirsizli\u011fi yans\u0131t\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Patent s\u00fcresi dolmas\u0131<\/strong>: Jakafi&#8217;nin nihai patent u\u00e7urumu riski<\/li>\n<li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez olabilir<\/li>\n<li><strong>Rekabet<\/strong>: Miyelofibroz tedavi alan\u0131nda yeni oyuncular<\/li>\n<li><strong>Ar-Ge ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: \u0130la\u00e7 hatt\u0131 ba\u015far\u0131s\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 ivmesi<\/strong>: Son \u00e7eyreklerde tutarl\u0131 a\u015fmalar<\/li>\n<li><strong>\u00dcr\u00fcn \u00e7e\u015fitlendirmesi<\/strong>: Opzelura&#8217;n\u0131n ba\u015far\u0131l\u0131 lansman\u0131 Jakafi ba\u011f\u0131ml\u0131l\u0131\u011f\u0131n\u0131 azalt\u0131yor<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: Stratejik sat\u0131n almalar i\u00e7in 2,4 milyar $<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: B\u00fcy\u00fcyen hassas t\u0131p pazar\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Geri \u00e7ekilmeyi bekleyin<\/strong>: Mevcut fiyatlar 52 haftal\u0131k zirvelere yak\u0131n, sab\u0131rl\u0131 olun<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Toplu yerine k\u00fc\u00e7\u00fck, d\u00fczenli yat\u0131r\u0131mlar\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Hisse 75-78 $ destek b\u00f6lgesine d\u00fc\u015ferse sat\u0131n al\u0131n<\/li>\n<li><strong>Portf\u00f6y\u00fc \u00e7e\u015fitlendirin<\/strong>: Biyoteknoloji tahsisini %5-10 ile s\u0131n\u0131rlay\u0131n<\/li>\n<\/ol>\n<p>Espiri: &#8220;INCY ticareti yapmak, klinik deneme sonu\u00e7lar\u0131n\u0131 beklemek gibidir &#8211; bazen o at\u0131l\u0131m an\u0131 i\u00e7in sab\u0131rl\u0131 olman\u0131z gerekir!&#8221;<\/p>\n<h2>\u2705 Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>INCY hakk\u0131nda kapsaml\u0131 ara\u015ft\u0131rma yap\u0131n<\/td>\n<td>\u015eirketin \u00fcr\u00fcnlerini ve risklerini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Giri\u015f stratejinizi belirleyin<\/td>\n<td>Al\u0131m fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyonunuzu izleyin ve y\u00f6netin<\/td>\n<td>Stop-loss ve kar hedefleri belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, INCY gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong> tek belgeli KYC ile h\u0131zl\u0131ca i\u015flem yapman\u0131z\u0131 sa\u011flar<\/li>\n<li><strong>Kripto paralar ve e-c\u00fczdanlar dahil<\/strong> \u00e7oklu para \u00e7ekme se\u00e7enekleri<\/li>\n<li><strong>Karma\u015f\u0131kl\u0131ktan uzak, kullan\u0131c\u0131 dostu platform<\/strong> yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015ft\u0131r<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, piyasalar\u0131 \u00f6\u011frenirken k\u00fc\u00e7\u00fck ba\u015flamay\u0131 isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Incyte: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Incyte Corporation, kanser tedavisinde yenilik\u00e7i yakla\u015f\u0131m\u0131yla hassas t\u0131p alan\u0131nda liderdir. \u015eirketin i\u015f modeli, <a href=\"https:\/\/dcfmodeling.com\/products\/incy-business-model-canvas\">onkoloji ve nadir hastal\u0131klar i\u00e7in hedefe y\u00f6nelik tedavilere<\/a> odaklanmakta olup, genomik test kapsam\u0131 ileri evre kanser hastalar\u0131n\u0131n %89&#8217;una ula\u015fmaktad\u0131r.<\/p>\n<p>\u015eirketin amiral gemisi ila\u00e7 <strong>Jakafi<\/strong> y\u0131lda yakla\u015f\u0131k 1,74 milyar $ gelir sa\u011flarken, <strong>Opzelura<\/strong> gibi yeni \u00fcr\u00fcnler y\u0131ll\u0131k %35 patlay\u0131c\u0131 b\u00fcy\u00fcme g\u00f6stermektedir. <a href=\"https:\/\/www.fiercepharma.com\/pharma\/incyte-ceo-turn-lot-cards-2025-eyes-2-types-deals\">2025 i\u00e7in planlanan d\u00f6rt \u00fcr\u00fcn lansman\u0131 ve d\u00f6rt kritik sonu\u00e7<\/a> ile \u015firket, kanser ve imm\u00fcnoloji alanlar\u0131nda yenilik yapmaya devam ediyor.<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Incyte&#8217;in ara\u015ft\u0131rmalar\u0131, molek\u00fcler profilleme yoluyla %93,7 hedefe y\u00f6nelik tedavi e\u015fle\u015fme oran\u0131 elde etti\u011fini g\u00f6steriyor; yani genomik test yapt\u0131ran neredeyse t\u00fcm hastalar uygun hedefe y\u00f6nelik tedavi ile e\u015fle\u015fiyor!<\/p>\n"},"faq":[{"question":"Incyte Corporation hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7erek, hesap a\u00e7\u0131p fonlad\u0131ktan sonra INCY hisselerini ara\u015ft\u0131rarak ve uygun fiyat seviyelerinde al\u0131m yaparak Incyte hisseleri sat\u0131n alabilirsiniz."},{"question":"Incyte hisselerinin fiyat\u0131 ne kadar?","answer":"28 A\u011fustos 2025 itibar\u0131yla Incyte hisseleri NASDAQ'da 84,84 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"Incyte hisseleri i\u00e7in riskler nelerdir?","answer":"Patent s\u00fcresi dolmas\u0131, reg\u00fclasyon zorluklar\u0131, artan rekabet ve Ar-Ge ba\u015far\u0131s\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Incyte hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 81-85 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 60-65 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir; ancak geni\u015f bir hedef aral\u0131\u011f\u0131 belirsizli\u011fi g\u00f6stermektedir."},{"question":"Yeni ba\u015flayanlar Incyte hisseleri i\u00e7in ne yapmal\u0131?","answer":"Sab\u0131rl\u0131 olmak, fiyat geri \u00e7ekilmelerini beklemek, dolar maliyeti ortalamas\u0131 yapmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek yeni ba\u015flayanlar i\u00e7in \u00f6nerilen stratejilerdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Incyte Corporation hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7erek, hesap a\u00e7\u0131p fonlad\u0131ktan sonra INCY hisselerini ara\u015ft\u0131rarak ve uygun fiyat seviyelerinde al\u0131m yaparak Incyte hisseleri sat\u0131n alabilirsiniz."},{"question":"Incyte hisselerinin fiyat\u0131 ne kadar?","answer":"28 A\u011fustos 2025 itibar\u0131yla Incyte hisseleri NASDAQ'da 84,84 $ seviyesinde i\u015flem g\u00f6rmektedir."},{"question":"Incyte hisseleri i\u00e7in riskler nelerdir?","answer":"Patent s\u00fcresi dolmas\u0131, reg\u00fclasyon zorluklar\u0131, artan rekabet ve Ar-Ge ba\u015far\u0131s\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Incyte hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 81-85 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 60-65 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir; ancak geni\u015f bir hedef aral\u0131\u011f\u0131 belirsizli\u011fi g\u00f6stermektedir."},{"question":"Yeni ba\u015flayanlar Incyte hisseleri i\u00e7in ne yapmal\u0131?","answer":"Sab\u0131rl\u0131 olmak, fiyat geri \u00e7ekilmelerini beklemek, dolar maliyeti ortalamas\u0131 yapmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek yeni ba\u015flayanlar i\u00e7in \u00f6nerilen stratejilerdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T09:46:51+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T09:46:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\",\"name\":\"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-28T09:46:51+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T09:46:51+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T09:46:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/","name":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-28T09:46:51+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":353739,"slug":"how-to-buy-incyte-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Incyte Corporation (INCY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"pt_AA":{"locale":"pt_AA","id":353737,"slug":"how-to-buy-incyte-corporation","post_title":"Como comprar a\u00e7\u00f5es da Incyte Corporation (INCY) - Investimento em a\u00e7\u00f5es da Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-incyte-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/353735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=353735"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/353735\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=353735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=353735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=353735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}